Immunoblot analysis showed that rHDGF treatment induced SOD2 upregulation in a dose-dependent manner but did not affect SOD1 protein levels in hepatoma cells (Fig. 7, A and B). The gene discussed is SOD2; the disease is hepatocellular carcinoma.